SCHEMBL6506387

SCHEMBL6506387

NC(=O)Nc1cn(-c2ccc(S(=O)(=O)c3ccc(F)cc3)cc2Cl)nc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.41
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA9 Q16790 3/20 0.37
CA12 O43570 2/20 0.37
CFTR P13569 4/20 0.36
SLC16A1 P53985 1/20 0.35
NR3C2 P08235 1/20 0.35
POLB P06746 2/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
NPY1R P25929 1/20 0.35
HTT P42858 1/20 0.35
NPY2R P49146 1/20 0.35
PAX8 Q06710 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507064 0.90 ITK (0.43) ITKCA1CA2CA9CA12
SCHEMBL6468046 0.88 ITK (0.43) ITKCA1CA2CA9CA12
SCHEMBL6468270 0.84 CA9 (0.48) ITKCA1CA2CA9CA12
SCHEMBL6506908 0.82 ITK (0.42) ITKNR3C2POLBLMNAKMT2A
SCHEMBL6469876 0.82 HSD11B1 (0.42) ITKCA1CA2CA9CA12
SCHEMBL6468684 0.79 ITK (0.47) ITKPOLBKMT2AKDM4EMEN1
SCHEMBL6470265 0.78 ITK (0.42) ITKCA1CA2CA9CA12
SCHEMBL6507544 0.76 NAMPT (0.41) ITKCA1CA2CA9CA12
SCHEMBL6467527 0.75 KDM4E (0.47) ITKCA1CA2CA9CA12
SCHEMBL6467428 0.74 ITK (0.47) ITKKMT2AKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885CA1 3159/4885CA2 3703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.